With Chikungunya virus transmission occurring in approximately 100 countries in Africa, Asia, and the Americas and significant outbreaks reported in May 2025, researchers have identified an effective method to reduce this mosquito-transmitted disease's impact on local communities.
The findings from a new study suggest that the newly approved chikungunya vaccine represents an important new tool for controlling outbreaks.
Read More
